OCGN Competitors & Alternatives
Compare Ocugen Inc with similar stocks in the same industry
Biotechnology
OCGN
Main Stock$0.79
Tradestie Score
53
Market Cap
$524.67M
Revenue Growth
0.1%
Analyst Upside
+1440.1%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.59
|
$307.12M | - | 61 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.38
|
$304.12M | - | 60 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$14.91
|
$297.23M | - | 50 | Compare |
|
OMER
Omeros Corporation
|
$16.86
|
$281.75M | 13.6 | 60 | Compare |
|
DBVT
DBV Technologies S.A.
|
$9.68
|
$275.54M | - | 61 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.94
|
$269.08M | 0.1 | 64 | Compare |
|
PBYI
PUMA BIOTECHNOLOGY INC
|
$11.26
|
$265.45M | 21.0 | 39 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$24.28
|
$256.54M | - | 66 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.66
|
$240.89M | - | 35 | Compare |
More OCGN Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
224 stocks in this industry